BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17902502)

  • 1. Analysis of weight, packed cell volume changes and menstrual pattern in Norplant implant acceptors in Ilorin, Nigeria.
    Balogun OR
    Niger J Clin Pract; 2007 Jun; 10(2):116-9. PubMed ID: 17902502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic function in Norplant (levonorgestrel) users: a 3-year prospective experience in Benin-City, Nigeria.
    Aisien AO; Enosolease ME
    Niger Postgrad Med J; 2009 Jun; 16(2):126-31. PubMed ID: 19606192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of haemostatic function in Nigerian Norplant acceptors after 12 months of use.
    Aisien AO; Enosolease ME; Shobowale MO
    J Obstet Gynaecol; 2005 May; 25(4):377-81. PubMed ID: 16091325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of menstrual and haematological parameters, after 36 months of Norplant contraception.
    Aisien AO; Sagay AS; Imade GE; Ujah IA; Nnana OU
    J Obstet Gynaecol; 2002 Jul; 22(4):406-10. PubMed ID: 12521466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norplant implants in Ethiopia.
    Argina H; Lukman HY
    East Afr Med J; 1997 Apr; 74(4):258-62. PubMed ID: 9299831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraception with levonorgestrel subdermal implants (Norplant) in Benin-City, Nigeria: a 12-year review.
    Aisien AO
    Afr J Reprod Health; 2007 Apr; 11(1):90-7. PubMed ID: 17982951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of safety, efficacy, and acceptability of NORPLANT implants in Sri Lanka.
    Basnayake S; Thapa S; Balogh SA
    Stud Fam Plann; 1988; 19(1):39-47. PubMed ID: 3129828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of Norplant in Kumasi, Ghana.
    Martey JO; Turkson SO; Djan JO; Dunson TR; Amatya R; Krueger S
    East Afr Med J; 1995 Jun; 72(6):381-5. PubMed ID: 7498011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual changes during Norplant use and return of fertility following Norplant implant removal: the Singapore experience.
    Singh K; Viegas OA; Ratnam SS
    Adv Contracept Deliv Syst; 1991; 7(2):139-45. PubMed ID: 12284216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic changes among Nigerian Norplant users.
    Sagay AS; Okeahialam BN; Imade GE
    West Afr J Med; 2002; 21(2):146-8. PubMed ID: 12403039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the acceptability and effectiveness of Norplant (R) contraceptive implants in Kuala Lumpur, Malaysia.
    Arshat H; Rachagan SP; Kwa Siew Kim ; Ang Eng Suan ; Karim HA; Ismail MT
    Malays J Reprod Health; 1990 Jun; 8(1):21-9. PubMed ID: 12316341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Norplant contraceptive use on hemoglobin, packed cell volume and menstrual bleeding patterns.
    Fakeye O; Balogh S
    Contraception; 1989 Mar; 39(3):265-74. PubMed ID: 2496950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
    Biswas A; Biswas S; Viegas OA
    Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the pre-introduction of contraception by means of subcutaneous levonorgestrel implants in Burkina Faso].
    Lankoande J; Ouedraogo A; Dao B; Ouedraogo CM; Bonane B; Toure B; Ouattara T; Kabore I; Millogo B; Kone B
    Dakar Med; 1998; 43(1):79-82. PubMed ID: 9827162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmenstrual adverse events associated with subdermal contraceptive implants containing normegestrel and levonorgestrel.
    Arowojolu AO; Ladipo OA
    Afr J Med Med Sci; 2003 Mar; 32(1):27-31. PubMed ID: 15030062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menstrual bleeding patterns in Chinese women using the Norplant subdermal implant.
    Fan M; Sujuan G
    Hum Reprod; 1996 Oct; 11 Suppl 2():14-9. PubMed ID: 8982740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with side effects and health risks associated with Norplant implant use in adolescents.
    Rosenthal SL; Biro FM; Kollar LM; Hillard PJ; Rauh JL
    Contraception; 1995 Nov; 52(5):283-5. PubMed ID: 8585884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and complications of Norplant use in Calabar.
    Ekabua JE; Itam IH
    Trop Doct; 2007 Jan; 37(1):37-9. PubMed ID: 17326887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.